FDA would require drug supply chain labels to go public

What does this do?

This bill requires drug manufacturers to tell the federal government who supplies each ingredient in their drugs and how much of the drug came from each supplier. Reports could be required up to four times a year. Drug labels and package documents would also have to show the name, location, and a unique ID number for every company involved in making, packing, or distributing the drug.

Who does it affect?

Drug manufacturers, ingredient suppliers, and distributors would face new reporting and labeling requirements. Consumers and pharmacists would be able to see more detail about where drugs and their ingredients are made.

Why does it matter?

Because more sourcing information would appear on labels and in government reports, the origin of a drug and its ingredients would be more traceable. The Food and Drug Administration would be responsible for writing the rules that define exactly what must be reported and how it must appear on labels.

Where does it stand?